Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-20-000032

Chief Legal Officer gave up 2,529 shares (to pay taxes)

  • Chief Legal Officer acquired 8,523 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Biller Jonathan · Chief Legal Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-04-13 Exercise or conversion : show line 1 in the form +8,523 8,523 D
2020-04-14 Shares withheld for taxes : show line 2 in the form −2,529 $40.64 $102,779 5,994 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-04-13 Exercise or conversion : show line 3 in the form Performance share units −8,523 17,045 D
Loading xslF345X03/wf-form4_158698240592447.xml…